(MT Newswires) -- Dutch Philips Group (PHG) CEO Roy Jakobs discusses the consequences of the sleep apnea machine recall. The Dutch medical equipment manufacturer has not given a definitive figure for the cost of the recall, as the legal proceedings are not over, but claims that 99% of defective devices have been replaced. While the company has recorded three consecutive quarters of growth, it points to investments in artificial intelligence, estimated at over a billion euros a year.

Bloomberg videos